Category | Big biotech

Athersys and Chugai announce pharma licensing deal for ischemic stroke

Posted on 03 March 2015

Athersys and Chugai Pharmaceutical have announced a partnership and pharma licensing agreement to exclusively develop and commercialize MultiStem cell therapy for ischemic stroke in Japan.

Tags: , , , ,

Teva enters into pharma licensing deal with Eagle Pharmaceuticals for cancer drug

Posted on 18 February 2015

Teva Pharmaceutical Industries has entered into a $120 million pharma licensing agreement that will allow it to distribute and promote a competitor to its own cancer drug, Eagle Pharmaceuticals EP-3102.

Tags: , , , ,

Genzyme and Voyager in $845 million AAV gene therapy pact

Posted on 12 February 2015

Voyager Therapeutics and Genzyme announced a major strategic collaboration to discover, develop and commercialize novel gene therapies for severe CNS disorders

Tags: , , ,

Biogen Idec enters hemophilia academic research pact

Posted on 02 February 2015

Biogen Idec, Fondazione Telethon and Ospedale San Raffaele have entered into a worldwide collaboration to jointly develop gene therapies for the treatment of both hemophilia A and B

Tags: , , ,

Gilead and EnvisionRx partner for Sovaldi and Harvoni distribution

Posted on 27 January 2015

EnvisionRx announced a partnership with Gilead Sciences to provide availability to HCV infection treatments Sovaldi and Harvoni

Tags: , , ,

Celgene and Zymeworks partner for bi-specific antibody therapeutics

Posted on 22 January 2015

Zymeworks announced a collaboration and licensing agreement with Celgene for the research, development, and commercialization of bi-specific antibody therapeutics enabled using Zymeworks’ proprietary Azymetric platform

Tags: , , ,

Celgene licenses AG-120 from Agios

Posted on 14 January 2015

Agios Pharmaceuticals announced that its collaboration partner Celgene has agreed that it will exercise its option to obtain an exclusive license outside the United States for AG-120

Tags: , , ,

Amgen and MD Anderson in bispecific T cell engager (BiTE) antibody pact

Posted on 14 January 2015

Amgen and The University of Texas MD Anderson Cancer Center announced a research collaborative agreement focusing on Amgen’s bispecific T cell engager (BiTE) antibody constructs

Tags: , ,

Vedanta and Janssen partner for VE202

Posted on 14 January 2015

Vedanta Biosciences announced a license agreement with Janssen Biotech, for Vedanta’s lead microbiome pharmaceutical candidate (VE202)

Tags: , , ,

BMS and Seattle evaluate Adcetris and Opdivo combination

Posted on 13 January 2015

Seattle Genetics and Bristol-Myers Squibb have entered into a clinical trial collaboration agreement to evaluate the investigational combination of Seattle Genetics’ antibody-drug conjugate (ADC) Adcetris (brentuximab vedotin) and Bristol-Myers Squibb’s immunotherapy Opdivo (nivolumab) in two planned Phase 1/2 clinical trials

Tags: , ,